Skip to main content

Table 5 Odds of discontinuation during the 6-month study period among women in need of modern contraception

From: Task-shifting and family planning continuation: contraceptive trajectories of women who received their method at a community-based event in Kinshasa, DRC

Independent variables

Model 1

Model 2

Model 3

OR

p-value

OR

p-value

OR

p-value

Experience with method

      

Experienced side effects (after baseline)

1.70

0.072

5.69

 < 0.001

1.60

0.128

Was able to resupply method at least once

0.01

 < 0.001

Baseline counseling experience

      

Intended to continue using FP at baseline

0.27

0.273

0.24

0.192

0.87

0.882

Did not obtain preferred method at baseline

0.27

0.008

1.19

0.738

1.15

0.753

Was told where to resupply (ref: No)

      

 Yes, community location

3.43

0.003

0.58

0.157

 Yes, health facility

3.66

 < 0.001

0.49

0.033

 Yes, pharmacy

0.75

0.651

0.41

0.103

 Yes, other

0.47

0.717

0.56

0.749

History of FP use

      

Ever use modern contraception

2.32

0.025

1.37

0.381

0.53

0.054

Ever used that method previously

0.95

0.917

0.46

0.046

0.56

0.075

Sociodemographics

      

Age group (ref: 15–24)

      

 25–34

0.98

0.960

0.67

0.327

0.55

0.089

 35–49

1.57

0.474

0.75

0.623

0.76

0.596

Education level (ref: none)

      

 Primary

1.46

0.490

0.82

0.731

0.99

0.980

 Secondary or higher

1.51

0.489

0.65

0.477

1.37

0.566

Married/living in union

0.36

0.006

0.31

0.001

0.59

0.091

Number of living children

0.92

0.578

1.21

0.184

1.14

0.293

Desired time until next child (ref: < 1 year)

      

 1–2 year

1.70

0.079

0.31

0.196

0.30

0.304

 2+ years

0.11

0.026

0.27

0.143

0.33

0.332

 No more children

0.13

0.064

0.25

0.175

0.28

0.312

Observations

869

 

530

 

388

 
  1. The sample for model 1 consists of all clients, the sample for model 2 consists of women who selected a short-acting method at baseline, and the sample for model 3 consists of women who selected a short-acting method at baseline which requires routine resupply (oral pills, DMPA-SC). EC users have been excluded from all models due to the small sample size (n = 7)